- What is MeMed Diagnostics' primary focus?
- MeMed Diagnostics specializes in developing diagnostic tools for infectious diseases, specifically an immune-based protein signature, MeMed BV, to differentiate between bacterial and viral infections.
- When was MeMed Diagnostics founded?
- MeMed Diagnostics was founded in June 2009.
- What was the most recent funding round for MeMed Diagnostics?
- In August 2021, MeMed Diagnostics raised $93,000,000. Investors included La Maison Partners and OurCrowd.
- What is the total amount of funding MeMed Diagnostics has raised to date?
- MeMed Diagnostics has raised a total of $223,429,159 across all funding rounds.
- How many employees does MeMed Diagnostics have?
- MeMed Diagnostics has 51-200 employees.
- Has MeMed Diagnostics received FDA clearance for its products?
- Yes, in September 2021, MeMed Diagnostics was granted 510(k) clearance by the FDA for MeMed BV for adults and children.
- What is MeMed Key?
- MeMed Key is a platform being developed by MeMed Diagnostics to measure multiple proteins and signatures with central lab precision at the point of care, capable of measuring MeMed BV within minutes.
- Which organizations have provided grants to MeMed Diagnostics?
- MeMed Diagnostics has received grants from organizations such as EU Horizon 2020, U.S. Department of Defense, and European Innovation Council (EIC).